Interpretation of treatment changes in 6-minute walk distance in patients with COPD

M. A. Puhan, M. J. Mador, U. Held, R. Goldstein, G. H. Guyatt, H. J. Schünemann

Research output: Contribution to journalArticle

Abstract

There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists. Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated. Data were included of 460 COPD patients with a mean±SD forced expiratory volume in one second (FEV1) of 39.2±14.1% predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95% confidence interval 30-42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates. 6-min walk distance should change by ∼35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10% change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance. Copyright

Original languageEnglish (US)
Pages (from-to)637-643
Number of pages7
JournalEuropean Respiratory Journal
Volume32
Issue number3
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Therapeutics
Forced Expiratory Volume
Uncertainty
Outcome Assessment (Health Care)
Confidence Intervals

Keywords

  • 6-min walk distance
  • Chronic obstructive pulmonary disease
  • Exercise test
  • Interpretation
  • Randomised trials

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Puhan, M. A., Mador, M. J., Held, U., Goldstein, R., Guyatt, G. H., & Schünemann, H. J. (2008). Interpretation of treatment changes in 6-minute walk distance in patients with COPD. European Respiratory Journal, 32(3), 637-643. https://doi.org/10.1183/09031936.00140507

Interpretation of treatment changes in 6-minute walk distance in patients with COPD. / Puhan, M. A.; Mador, M. J.; Held, U.; Goldstein, R.; Guyatt, G. H.; Schünemann, H. J.

In: European Respiratory Journal, Vol. 32, No. 3, 09.2008, p. 637-643.

Research output: Contribution to journalArticle

Puhan, MA, Mador, MJ, Held, U, Goldstein, R, Guyatt, GH & Schünemann, HJ 2008, 'Interpretation of treatment changes in 6-minute walk distance in patients with COPD', European Respiratory Journal, vol. 32, no. 3, pp. 637-643. https://doi.org/10.1183/09031936.00140507
Puhan, M. A. ; Mador, M. J. ; Held, U. ; Goldstein, R. ; Guyatt, G. H. ; Schünemann, H. J. / Interpretation of treatment changes in 6-minute walk distance in patients with COPD. In: European Respiratory Journal. 2008 ; Vol. 32, No. 3. pp. 637-643.
@article{5487f8e1fccd4558b27e6d87686af78d,
title = "Interpretation of treatment changes in 6-minute walk distance in patients with COPD",
abstract = "There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists. Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated. Data were included of 460 COPD patients with a mean±SD forced expiratory volume in one second (FEV1) of 39.2±14.1{\%} predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95{\%} confidence interval 30-42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates. 6-min walk distance should change by ∼35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10{\%} change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance. Copyright",
keywords = "6-min walk distance, Chronic obstructive pulmonary disease, Exercise test, Interpretation, Randomised trials",
author = "Puhan, {M. A.} and Mador, {M. J.} and U. Held and R. Goldstein and Guyatt, {G. H.} and Sch{\"u}nemann, {H. J.}",
year = "2008",
month = "9",
doi = "10.1183/09031936.00140507",
language = "English (US)",
volume = "32",
pages = "637--643",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - Interpretation of treatment changes in 6-minute walk distance in patients with COPD

AU - Puhan, M. A.

AU - Mador, M. J.

AU - Held, U.

AU - Goldstein, R.

AU - Guyatt, G. H.

AU - Schünemann, H. J.

PY - 2008/9

Y1 - 2008/9

N2 - There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists. Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated. Data were included of 460 COPD patients with a mean±SD forced expiratory volume in one second (FEV1) of 39.2±14.1% predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95% confidence interval 30-42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates. 6-min walk distance should change by ∼35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10% change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance. Copyright

AB - There is uncertainty about the interpretation of changes in the 6-min walk distance (6MWD) in chronic obstructive pulmonary disease (COPD) patients and whether the minimal important difference (MID) for this useful outcome measure exists. Data were used from nine trials enrolling a wide spectrum of COPD patients with 6MWD at baseline and follow-up and used to determine threshold values for important changes in 6MWD using three distribution-based methods. Anchor-based methods to determine a MID were also evaluated. Data were included of 460 COPD patients with a mean±SD forced expiratory volume in one second (FEV1) of 39.2±14.1% predicted and 6MWD of 361±112 m at baseline. Threshold values for important effects in 6MWD were between 29 and 42 m, respectively, using the empirical rule effect size and the standardised response mean. The threshold value was 35 m (95% confidence interval 30-42 m) based on the standard error of measurement. Correlations of 6MWD with patient-reported anchors were too low to provide meaningful MID estimates. 6-min walk distance should change by ∼35 m for patients with moderate to severe chronic obstructive pulmonary disease in order to represent an important effect. This corresponds to a 10% change of baseline 6-min walk distance. The low correlations of 6-min walk distance with patient-reported anchors question whether a minimal important difference exists for the 6-min walk distance. Copyright

KW - 6-min walk distance

KW - Chronic obstructive pulmonary disease

KW - Exercise test

KW - Interpretation

KW - Randomised trials

UR - http://www.scopus.com/inward/record.url?scp=58149401115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149401115&partnerID=8YFLogxK

U2 - 10.1183/09031936.00140507

DO - 10.1183/09031936.00140507

M3 - Article

C2 - 18550610

AN - SCOPUS:58149401115

VL - 32

SP - 637

EP - 643

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 3

ER -